Daihan Pharmaceutical

Daihan Pharmaceutical is a prominent South Korean pharmaceutical company that specializes in the manufacture of essential medical solutions, particularly large-volume parenterals (LVP) and small-volume parenterals (SVP). Established in 1945, the company is a market leader in the domestic production of basic intravenous (IV) fluids, including saline, dextrose, and electrolyte solutions. Beyond its core infusion business, Daihan produces a diverse portfolio of finished pharmaceuticals covering respiratory, circulatory, and nutritional therapeutic areas. The company operates high-standard manufacturing facilities in Ansan, South Korea, which are KGMP-certified to ensure the quality of its life-saving medical supplies. Daihan is publicly traded on the KOSDAQ and continues to expand its presence in the hospital-based medicine sector through continuous process optimization and product diversification. It is recognized as one of the critical infrastructure providers for the South Korean healthcare system due to its dominant share in the essential IV fluid market.